The goal of this study was to reduce the salivary symptoms of pain and xerostomia caused
by 131I therapy for papillary and follicular thyroid carcinoma. Methods: In a single-blind …

Background: The ability of sialagogues to increase or decrease radiation induced-
sialoadenitis and/or xerostomia after therapeutic administration of 131I is controversial. To …

sented a retrospectivestudy of the frequencyof sialadenitis following iodine-13l (â€@ †1)
therapy (1). In ten of87 patients there were subjective findings of sialadenitis. They pointed …

During a 4-yr period, ten of 87 patients (11.5%) who received therapeutic doses of
radioactive iodine (I-131) for thyroid carcinoma developed acute and/or chronic sialadenitis …

Salivary gland dysfunction is one of the common side effects of high-dose radioiodine
therapy for thyroid cancer. The purpose of this study was to determine whether an early start …

Purpose Sialadenitis is a well-recognized adverse effect of high-dose radioactive iodine
treatment. This study was undertaken to determine whether Tc-99m pertechnetate salivary …

Objective The protective effect of sialagogues following 131 I therapy became controversial
after a study proposed that sialagogues increase the reaccumulation of 131 I in the parotid …

AIMS: Salivary gland toxicity is a common, but not widely appreciated, adverse effect of high-
dose radioiodine (131I). This study was carried out to determine the incidence of symptoms …

Background: To decrease the severity and frequency of radiation sialoadenitis,
postponement of the use of sialagogues has been proposed for the first 24 hours after 131I …

Objective The aim of this study was to document the subjective and objective findings of
symptomatic late-onset sialadenitis after radioiodine therapy in patients with differentiated …